Anti-TNF (adalimumab) injection for the treatment of pain-predominant early-stage frozen shoulder: the Anti-Freaze-Feasibility randomised controlled trial.

导出 OA

翻译打印收藏纠错

作者： Sally,Hopewell ^[1] ; Cynthia,Srikesavan ^[2] ; Alison,Evans ^[3] ; Fema,Er ^[4] ; Amar,Rangan ^[5] ; Jane,Preece ^[6] ; Anne,Francis ^[4] ; M Sofia,Massa ^[4] ; Marc,Feldmann ^[3] ; Sarah,Lamb ^[7] ; Jagdeep,Nanchahal ^[3]

作者单位： Oxford Clinical Trials Research Unit, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK sally.hopewell@csm.ox.ac.uk. ^[1] Centre for Rehabilitation Research in Oxford, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.;College of Medicine and Health, University of Exeter, Exeter, UK. ^[2] Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK. ^[3] Oxford Clinical Trials Research Unit, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK. ^[4] South Tees Hospitals NHS Foundation Trust, The James Cook University Hospital, Middlesbrough, UK.;Department of Health Sciences, University of York, York, UK. ^[5] Patient and Public Involvement Representative, Kidderminster, UK. ^[6] College of Medicine and Health, University of Exeter, Exeter, UK. ^[7]

关键词 Musculoskeletal disorders Patients Shoulder